Rosiglitazone Does Not Improve Cognition or Global Function when Used as Adjunctive Therapy to AChE Inhibitors in Mild-to-Moderate Alzheimers Disease: Two Phase 3 Studies
Year: 2011
Type: article
Study design: Clinical Trial
Source: Current Alzheimer Research
Institution: GlaxoSmithKline (United States)
Language: English
Subfield: Cellular and Molecular Neuroscience
Field: Neuroscience
Domain: Life Sciences
Open Access status: closed
Funders: Bristol-Myers Squibb, GlaxoSmithKline
OpenAlex ID: W2146876810
